CIBC Bancorp USA’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$328M Sell
485,314
-59,540
-11% -$35.4M 0.41% 52
2026
Q2
$273M Sell
544,854
-100,157
-16% -$48.1M 0.33% 67
2026
Q1
$317M Buy
+645,011
New +$350M 0.43% 52
2025
Q3
$25.3M Buy
+52,093
New +$24.2M 0.14% 114

Other funds holding TMO

CIBC Bancorp USA's TMO Position: Q3 2026 in Review

CIBC Bancorp USA reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q3 2026, selling an estimated $35.4M and leaving 485,314 shares worth $328M. The position accounts for 0.41% of the portfolio, ranked #52.

CIBC Bancorp USA first reported a position in TMO in Q3 2025 and has held it in 4 quarters since. 2,806 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • CIBC Bancorp USA held 485,314 shares of Thermo Fisher Scientific worth $328M as of Q3 2026.
  • CIBC Bancorp USA sold 59,540 Thermo Fisher Scientific shares in Q3 2026, an estimated $35.4M.
  • Thermo Fisher Scientific made up 0.41% of CIBC Bancorp USA's portfolio in Q3 2026, its #52 holding.
  • CIBC Bancorp USA first reported a position in Thermo Fisher Scientific in Q3 2025 and has held it in 4 quarters since.
  • 2,806 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.